The estimated Net Worth of Nancy E Katz is at least $76.5 Thousand dollars as of 30 April 2024. Ms. Katz owns over 5,396 units of Neurometrix stock worth over $30,331 and over the last 14 years she sold NURO stock worth over $0. In addition, she makes $46,130 as Independent Director at Neurometrix.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Ms. Katz NURO stock SEC Form 4 insiders trading
Nancy has made over 2 trades of the Neurometrix stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 5,396 units of NURO stock worth $23,581 on 30 April 2024.
The largest trade she's ever made was exercising 17,647 units of Neurometrix stock on 2 May 2023 worth over $70,410. On average, Nancy trades about 720 units every 11 days since 2010. As of 30 April 2024 she still owns at least 7,602 units of Neurometrix stock.
You can see the complete history of Ms. Katz stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Nancy Katz biography
Nancy E. Katz serves as Independent Director of the Company. From May 2011 to August 2014, Ms. Katz served as Vice President, Consumer Marketing at Medtronic, Inc., a medical technology company. From July 2005 to July 2010, Ms. Katz was Senior Vice President, Bayer Diabetes Care — North America. Prior to this position, she was President and Chief Executive Officer of Calypte Biomedical Corporation, a manufacturer of HIV diagnostics, President of Zila Pharmaceutical, Inc., a manufacturer of oral care products, and held senior marketing positions with the Lifescan division of Johnson & Johnson (blood glucose diabetes products), Schering-Plough Healthcare Products, and with American Home Products. Since October 2016, Ms. Katz has served on the Board of Directors of Cyanotech Corporation (Nasdaq: CYAN). She has previously served on the Boards of Directors of Neoprobe Corporation (AMEX: NEOP), Calypte Biomedical Corporation, LXN Corporation and Pepgen Corporation. She received a B.S. in business from the University of South Florida. The Board has concluded that Ms. Katz should serve as a director because her experience in diabetes care and marketing into the diabetes sector provides valuable insight to the Board and management in our diabetes strategy.
What is the salary of Nancy Katz?
As the Independent Director of Neurometrix, the total compensation of Nancy Katz at Neurometrix is $46,130. There are 4 executives at Neurometrix getting paid more, with Shai Gozani having the highest compensation of $775,030.
How old is Nancy Katz?
Nancy Katz is 60, she's been the Independent Director of Neurometrix since 2010. There are 4 older and 3 younger executives at Neurometrix. The oldest executive at Neurometrix Inc. is Thomas T. Higgins, 69, who is the Sr. VP, CFO & Treasurer.
What's Nancy Katz's mailing address?
Nancy's mailing address filed with the SEC is C/O NEUROMETRIX, INC., 4B GILL STREET, WOBURN, MA, 01801.
Insiders trading at Neurometrix
Over the last 20 years, insiders at Neurometrix have traded over $14,886,276 worth of Neurometrix stock and bought 3,074,896 units worth $6,396,868 . The most active insiders traders include James Edeerfield Capital Lp..., Capital Partners, Lp Topline, and Capital Management, Llc Mc .... On average, Neurometrix executives and independent directors trade stock every 45 days with the average trade being worth of $133,905. The most recent stock trade was executed by Thomas T Higgins on 2 May 2024, trading 498 units of NURO stock currently worth $2,226.
What does Neurometrix do?
neurometrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. the company maintains an active research effort and has several pipeline programs. the company is located in waltham, massachusetts and was founded as a spinoff from the harvard-mit division of health sciences and technology in 1996. for more information, please visit neurometrix.com. neurometrix markets the following products: quell® wearable pain relief technology™ quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. it combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. quell launc
What does Neurometrix's logo look like?
Complete history of Ms. Katz stock trades at Cyanotech and Neurometrix
Neurometrix executives and stock owners
Neurometrix executives and other stock owners filed with the SEC include:
-
Shai Gozani,
Chairman of the Board, President, Chief Executive Officer, Secretary, Director -
Thomas Higgins,
Chief Financial Officer, Senior Vice President, Treasurer -
Francis McGillin,
Senior Vice President, Chief Commercial Officer -
Thomas T. Higgins,
Sr. VP, CFO & Treasurer -
Nancy Katz,
Independent Director -
David Goodman,
Independent Director -
Dr. Shai N. Gozani,
Founder, Chairman, CEO, Pres & Sec. -
David Van Avermaete,
Independent Director -
Susan M. Bell R.N.,
Sr. VP of Population Health & Value Based Medicine -
Dr. Xuan Kong Ph.D.,
Chief Data Scientist -
Michael J. MacDonald,
Sr. VP of Commercial Operations & GM of Diagnostics -
Capital Management Viii Llc...,
10% owner -
Allen J Hinkle,
Director -
Timothy R Surgenor,
Director -
Capital Absolute Return Fun...,
10% owner -
Capital Partners Viii, L.P....,
10% owner -
Gary Gregory,
Chief Operating Officer -
W Bradford Smith,
Chief Financial Officer -
Capital Partners Vii L P In...,
10% owner -
Capital Management Vii, Llc...,
10% owner -
Absolute Return Management,...,
10% owner -
Joshua Horowitz,
Director -
Walter Christensen,
Sr. VP, Global Sales -
Charles R Lamantia,
Director -
James Edeerfield Capital Lp...,
-
Inc Neurometrix,
Senior Vice President & GM -
Strategic Partners Iii Lp W...,
10% owner -
Peter M Castleman,
10% owner -
William Jr Laverack,
Director -
& Co, Llc Whitney,
10% owner -
Jonathan T Md Lord,
Director -
J H Iii Lp Whitney,
10% owner -
Michael R Stone,
10% owner -
Michael Williams,
Sr. VP of Engineering -
J H Equity Partners Iii Llc...,
10% owner -
James H Fordyce,
10% owner -
Brien Daniel J O,
10% owner -
Guy Daniello,
Sr.VP of InformationTechnology -
Charles E/Ny Harris,
Director -
W Mark Lortz,
Director -
Joseph A Calo,
Principal Fin. & Acct. Officer -
Ventures, Inc. Banc Boston,
10% owner -
Degree Capital Corp. /Ny/ 180,
10% owner -
Bradley M Fluegel,
Director -
Capital Partners, Lp Topline,
10% owner -
Capital Management, Llc Mc ...,